Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
Renxi WangPublished in: Journal of translational medicine (2022)
Our analysis suggested a causal association between genetically increased serum 25OHD levels and reduced MS in the European population.